All Episodes
CME — 418 episodes · page 1 of 5
Tapinarof’s Place in Inflammatory Disease Treatment
Skin Barrier Maintenance in Atopic Dermatitis and Psoriasis
Various Benefits of Aryl Hydrocarbon Receptor Agonists
Managing Patient Expectations with Topical Therapies
Potential Impact of Aryl Hydrocarbon Activation on Pigment
Mechanism of Action for Aryl Hydrocarbon Receptor Agonists
Ready, Set, Act! Opportunities to Address Persistent Unmet Needs in Patients With HFrEF: A Case-Based Discussion
Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients With Multiple Myeloma
Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients
Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients With Multiple Myeloma
Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients
CKD-aP Uncovered Prevalence & Pathophysiology
When Itching Hurts: Quality of Life Disruption in CKD-aP
Gabapentinoids: Safety Considerations and Downstream Outcomes
From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
Spotlight on Assessment: Tools That Capture CKD-aP
Reading Between the Lines: What PROMs Reveal About Itch
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
What You Don’t See: A Patient’s View of Living with CKD-aP
Winning the CKD-aP Battle: A United Physician-Nurse Front
Conference Coverage at ICCBH 2026: From Achondroplasia Presentation to Practice
Menin Inhibitors in AML: Six Clinical Showdowns That Shape Real-World Practice
Case Consult: Personalizing First-Line Maintenance Therapy in Advanced Ovarian Cancer
Case Consult: PD-L1–Guided Treatment Decisions in Platinum-Resistant Ovarian Cancer
Case Consult: Treatment Strategies for FRα-Positive Platinum-Resistant Ovarian Cancer
Case Consult: Treatment Strategies for HER2-Positive Platinum-Resistant Ovarian Cancer
Case Consult: Targeting CDH6 in Platinum-Resistant Ovarian Cancer
Raising the Bar for Hodgkin Lymphoma: Optimizing Immunotherapy in Community Practice
Rewriting the Calcium Code in ADH1
The Survival Ceiling in ES-SCLC: Why Checkpoint Blockade Alone Is Not Enough
Rationale of Emerging Antigen-Directed Strategies in Frontline ES-SCLC
Clinical Evidence on Emerging Antigen-Directed Strategies in ES-SCLC
On the Horizon: Emerging Antigen-Directed Strategies Across Disease Stage
Translating Research Into Practice in Breast Cancer: Emerging Data and the Expanding Role of ADCs
Advancing Acromegaly Care: Diving Deeper Into Diagnosis, Guideline Application, and Emerging Therapies—A Fireside Chat With Expert Perspectives
The Case for Change: Why Perioperative Immunotherapy Matters in LA HNSCC
The Evidence Base: Key Trials and Emerging Data
Building the Team: Integrating Immunotherapy Into Multidisciplinary Care
From Data to Decision: Patient Selection and Real-World Application
From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
Cracking the Code: Risk Stratification Guidelines to Identify High-Risk Patients
The Power of Timing: Therapies That Change Outcomes
ADT Intensification in Biochemically Recurrent Prostate Cancer: When to Act
Precision in Practice—Bringing Targeted Therapy to mHSPC
Clear Skin, Clear Path: Transforming Psoriasis Care with Durable Biologic and Oral IL-23 Innovations
Diagnosing Rett Syndrome: A Lifespan Approach to Clinical Recognition
Clinical Pearls in Recognizing Rett Syndrome: Early Signs and Diagnosis
Managing Rett Syndrome: Building a Multidisciplinary Care Approach
Clinical Pearls in Rett Syndrome Management: Practical Approaches to Multidisciplinary Care
Managing Rett Syndrome: Building a Multidisciplinary Care Approach
Clinical Pearls in Adult Rett Syndrome Care: Supporting Long-Term Needs
Transitioning to Adult Care in Rett Syndrome: Navigating Challenges
Clinical Pearls in Transition: Supporting Patients and Families Into Adulthood
Current Unmet Needs in First-Line Treatment of Metastatic TNBC
Comparing First-Line TROP2-Directed ADCs in Metastatic TNBC: Latest Clinical Evidence
Case Consult: First-Line Treatment in Metastatic TNBC Ineligible for Immunotherapy
Managing Adverse Events Associated With TROP2-Directed ADCs in Metastatic TNBC
What’s Next for TROP2-Directed ADCs in TNBC?
Translating Evidence on TROP2-Directed ADCs Into Global Practice in Metastatic TNBC
Novel Strategies for Managing EGFR-mutated mNSCLC: Expert Insights into the Latest Data and Recommendations
Mechanism to Match: Choosing the Right VMAT2 Strategy for the Patient
No Patient With CKD Left Behind: New Horizons in Patients With CKD Regardless of Diabetes Status
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
Optimizing Outcomes in Patients with FSGS: A Case-Based Approach in the New Era of Targeted Therapy
Chairperson’s Perspective: Incorporating Novel Treatment Options for Schizophrenia Into Clinical Practice - Overcoming Clinical Inertia
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
Why Staging TED Correctly Matters Even When CAS Is Low
Applying CAS, EUGOGO, VISA: A Micro Case
Why QoL Measures Change TED Management
Overcoming Real-World Barriers to TED Treatment
Designing Efficient Clinic Workflows for TED Therapy Access
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Cracking the Code in Localized, nmCSPC: Risk, Treatment, and Timing
The Future of mCSPC: Molecular Profiling and Biomarker-Directed Therapies
From Prevalence to Practice: Practical Screening and Workup for Hypercortisolism in Resistant Hypertension
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
Translating Evidence Into Action: Nonsteroidal MRAs in Patients With HF
Engaging Adult Patients With C3GN: Shared Decision-Making at the Crossroads of Complement-Targeted Therapy
De Novo mHSPC: Recognizing the Patients Who Need More
ADT Intensification: The Evidence You Can’t Afford to Miss
Case: Implementing ADT Intensification in mHSPC
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
Molecular Profiling in mHSPC: Informing Treatment Selection
Targeting PTEN: Why It Matters
AACE Guidance in Action: When to Suspect and Treat Hypercortisolism in Adults with Diabetes
Unblocking Clinical Inertia: The CMI Era in oHCM Care
IBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
Simple Diagnostic Steps That Change TD Outcomes & Increase Quality of Life
Leadoff Hitter – Spotting High-Risk Players
Swing for the Fences – LDL-C as the Power Hitter
Small Ball Wins Games – Combination Therapy for Goal Attainment
Extra Innings – Sustaining Victory Beyond the First Game
Turning the Double Play – Comprehensive Secondary Prevention
Crossing Home Plate – Building a Winning Team Culture
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
A Q-Challenge™ Replay: Advancing Precision Diagnosis and Treatment Strategies in Acromegaly